Osaic Holdings’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Osaic Holdings’s Portfolio PSTX Stock Details PSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1	Closed	-$10	–	7840
2024 Q4	$10	Buy	+1	New	+$5	﹤0.01%	7344
2022 Q3	–	Sell	-251	Closed	-$1K	–	7564
2022 Q2	$1K	Buy	+251	New	+$698	﹤0.01%	7190

Other funds holding PSTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings's PSTX Position: Q1 2025 in Review

Osaic Holdings sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 1 share — an estimated $10 sold.

Osaic Holdings first reported a position in PSTX in Q2 2022 and held it in 2 quarters. The position peaked at $1K in Q2 2022. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

Osaic Holdings reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Osaic Holdings sold 1 Poseida Therapeutics, Inc. Common Stock share in Q1 2025, an estimated $10.
Osaic Holdings first reported a position in Poseida Therapeutics, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
Osaic Holdings's Poseida Therapeutics, Inc. Common Stock position peaked at $1K in Q2 2022.
1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Osaic Holdings's 13F filing for Q1 2025, filed 12 May 2025.